Richard J. Rubino
2012
In 2012, Richard J. Rubino earned a total compensation of $772.6K as Chief Financial Officer at Aerie Pharmaceuticals.
Compensation breakdown
| Bonus | $10,080 |
|---|---|
| Option Awards | $700,000 |
| Salary | $62,500 |
| Total | $772,580 |
Rubino received $700K in option awards, accounting for 91% of the total pay in 2012.
Rubino also received $10.1K in bonus and $62.5K in salary.
Rankings
In 2012, Richard J. Rubino's compensation ranked 7,181st out of 11,487 executives tracked by ExecPay. In other words, Rubino earned more than 37.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,181 out of 11,487 | 38th |
Division Manufacturing | 2,568 out of 4,253 | 40th |
Major group Chemicals And Allied Products | 655 out of 1,198 | 45th |
Industry group Drugs | 452 out of 920 | 51st |
Industry Biological Products, Except Diagnostic Substances | 74 out of 160 | 54th |
Source: SEC filing on April 30, 2014.
Rubino's colleagues
We found one more compensation record of an executive who worked with Richard J. Rubino at Aerie Pharmaceuticals in 2012.
2012
Thomas van Haarlem
Aerie Pharmaceuticals
Chief Executive Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019